China brings revolution in treatment

Photo: Reuters

China brings a revolution in treatment - China wants to take steps for the medical sector. China has already moved forward in many areas of science and technology. The country wants to bring 'revolution' in treatment. Not only for the people but also for the whole world, in the field of biotechnology and medicine industry, China is trying to become a leading role.

Although the main requirement is in this case from China itself. According to one of the World Economic Forum, 20 million people from China will be 60 years old by 2020. As the number of elderly citizens continues to grow, China now needs different types of advanced medicines and various health technologies. Apart from this, one of the four cancer patients in the world currently facing cancer one of them in Chinese. So the country is trying to make the local drug industry to build its own capabilities. In addition, China wants to utilize the latest benefits of biotechnology. So, the country is investing in many biotechnology-related startups in Europe-America.

So much so that in the Western world, imported medicines in the world, China has fulfilled domestic demand. Along with this, thousands of Chinese medicine companies were making 'copy-paste' medicines. That means, Chinese companies have been producing and purchasing advanced drug formula licenses. The country has been stepping down from that position for years. Instead of preparing medicines in other formulas, China is trying to develop advanced medicines through research. Through the goal of China, once the Europe-America market is also seized. Analysts believe that in the near future China will be formed in the 'Powerhouse' of biotechnology.

Chinese Institute 'My Bio-Made' CEO and founder of this organization, says, "China is trying to move forward in innovation. In this case, efforts are being made to combine various aspects of health care with digital technology and artificial intelligence. That is, China is taking an initiative to formulate a balanced integration of IT with biotechnology.

This year, a company named Future Health Index has been created by the Philips Company. It has been found that China is ahead of all other countries in adopting digital health technology. In this case, the country is using telehealth and artificial intelligence.

China has already increased investment in this sector to take advantage of domestic medicines. A research institute named IQVIA says China was the second-largest consumer of pharmaceutical drugs in the year 2017. It is estimated that by 2022 the country's drug market will stand between 145 billion to 175 billion dollars.

An employee working in a biotechnology company in Beijing, China. Photo: AFP

The British journalist The Economist says that since 2015, the China Drug Administration (CDA) has started working to bring radical changes in the local market of medicine. In view of the growing older citizens, steps have been taken to accelerate the release of advanced medicines from outside the country. Reduced import duty. Apart from this, restrictions on local factories were also relaxed. Now the CDA is introducing strict rules for local drug manufacturers. This may lead to the closure of many Chinese companies. However, the policy of the Chinese regulatory body is to accept some damage - but walking on the road to better quality. It is said that this will result in long-term benefits from China. The reason is that the research department has to be strengthened to create better quality medicines. And this research will meet new innovations. As one has seen, China is currently spending 2.5 percent of its total GDP in the research sector. 

Now China has started buying drugs for several licenses. According to a report from the Financial Times, last year, only Chinese biotechnology companies have signed an agreement to purchase 164 international licenses. This figure is more than twice the number assumed five years ago. These contracts are about $ 14 billion. China is increasing the amount of investment in overseas startups Through this, the country wants to make new inventions so that the local and international markets can compete simultaneously. Similarly, China also increased investment in foreign information technology startups.

There is also darkness under the light. According to the World Health Organization, the situation is not as good as China's major city-based hospitals, in remote areas outside the city, the situation is not as good. The lack of primary health care is also visible. There is 1 doctor for 6,666 people in China. But according to the international standard, one to one and two thousand people per capita needs to have a doctor. In the remote areas of China, the number of hospitals is also inadequate, in some cases hundreds of miles are reached to reach a hospital. Analysts say that if the image does not change, the new health of Chinese medicine will not improve completely.

The number of patients infected with cancer in China is also increasing at alarming rates. According to the data from the China Cancer Foundation, 70 percent of patients with lung cancer are diagnosed with the disease and the treatment begins at the last stage. It is possible to identify the disease earlier in the preliminary examination of CT scans. But these facilities are not available in health centers outside the developed cities. As a result, residents of remote areas of the country are not benefiting from overall Chinese healthcare.

Of course, the Chinese government did not even sit. In the current study of cancer treatment, the peacock has been pouring money. Chinese scientists are already working on a new therapy named 'CAR-T' for cancer treatment. Understanding the opportunities, Westerners are investing in it.

It is true that China is moving in the way of comprehensive changes in the medical sector. But the speed of change is not guaranteed, it certainly never guarantees success. The new drug or biotechnology invention process is quite uncertain. Hopefully, China is starting to move forward in this way, knowing uncertain. Maybe one day we will go to China for better treatment!